Serial Number | 79346652 |
Word Mark | ADAR |
Filing Date | Saturday, May 7, 2022 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, October 11, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Cells for medical or clinical use; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; diagnostic reagents for medicinal use |
Goods and Services | Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals and genetics |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 5, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, August 5, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | EDIGENE INC. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | CN |
Event Date | Event Description |
Monday, January 29, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Wednesday, January 10, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, January 10, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
Wednesday, October 11, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Wednesday, October 11, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Wednesday, October 11, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Thursday, April 20, 2023 | REFUSAL PROCESSED BY IB |
Wednesday, March 29, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Wednesday, March 29, 2023 | REFUSAL PROCESSED BY MPU |
Tuesday, February 7, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Monday, February 6, 2023 | NON-FINAL ACTION WRITTEN |
Monday, February 6, 2023 | LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN |
Thursday, February 2, 2023 | ASSIGNED TO EXAMINER |
Sunday, December 18, 2022 | LETTER OF PROTEST EVIDENCE FORWARDED |
Tuesday, August 9, 2022 | APPLICATION FILING RECEIPT MAILED |
Friday, August 5, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, August 4, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |